Venous Thromboembolism Rates in Trauma Patients Significantly Increase With Missed Prophylactic Enoxaparin Doses
The American Surgeon™ · 2024
DOI: 10.1177/00031348241269401 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Surgeon™, 2024. Verfasst von Jess Spradling und 9 weiteren Autor:innen. Beteiligte Einrichtung: Butterworth Hospital, Corewell Health West, Grand Rapids, MI, USA. Hauptthemen laut MEDLINE: Enoxaparin, Venous Thromboembolism, Anticoagulants, Wounds and Injuries. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Background
Current literature demonstrates prophylactic enoxaparin to be efficacious in reducing venous thromboembolism (VTE) rates without significantly increasing risk for bleeding complications. Despite this evidence, prophylactic enoxaparin doses are frequently withheld for surgery or procedures. This exploratory study aims to quantify the risk of a VTE event in trauma patients associated with missed doses of prophylactic enoxaparin.
Methods
This retrospective cohort study evaluated trauma patients admitted to our Level 1 trauma center from January 1, 2012 to January 31, 2021. A 1:1 propensity match with ten variables was performed to compare patients receiving prophylactic enoxaparin that had a VTE and those that did not. The primary outcome was a VTE event.
Results
493 patients met inclusion criteria; 1:1 propensity score matching was performed resulting in a cohort of 184 patients. The percentage of patients that missed a prophylactic enoxaparin dose in the VTE group was higher than the no VTE group (34.8% vs 21.7%, P = 0.049). This is consistent when examining total missed doses ( P = 0.038) and consecutively missed doses ( P = 0.035). The odds of having a VTE for patients that missed at least one dose or more of enoxaparin are nearly two times greater (OR 1.92, 95% CI 0.997, 3.7).
Conclusion
Missing enoxaparin doses significantly increases the risk of VTE in matched populations. Most prophylactic enoxaparin doses were held for procedures, and not for bleeding events. Trauma teams should carefully weigh the risk of bleeding complications associated with continuing enoxaparin prophylaxis against the significant thromboembolic risk of withholding it.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Butterworth Hospital, Corewell Health West, Grand Rapids, MI, USA.
- College of Human Medicine, Michigan State University, Grand Rapids, MI, USA.
- Division Chief, Acute Care Surgery, Butterworth Hospital, Corewell Health West, Grand Rapids, MI, USA.
- Trauma Research Institute, Corewell Health West, Grand Rapids, MI, USA.
- Trauma and Acute Care Surgery, Corewell Health West, Grand Rapids, MI, USA.
- Scholarly Activity and Scientific Support, Corewell Health West, Grand Rapids, MI, USA.
ORCID-Profile: Steffen Pounders
Zitieren
APA
Spradling, J., Garfinkel, S., Edgecomb, T., Chapman, A. J., Pounders, S., Burns, K., Fisk, C. S., Stowe, A., Hill, E., & Krech, L. (2024). Venous Thromboembolism Rates in Trauma Patients Significantly Increase With Missed Prophylactic Enoxaparin Doses. The American Surgeon™. https://doi.org/10.1177/00031348241269401
Vancouver
Spradling J, Garfinkel S, Edgecomb T, Chapman AJ, Pounders S, Burns K, et al. Venous Thromboembolism Rates in Trauma Patients Significantly Increase With Missed Prophylactic Enoxaparin Doses. The American Surgeon™. 2024. doi:10.1177/00031348241269401
BibTeX
@article{Spradling2024,
author = {Spradling, Jess and Garfinkel, Sophia and Edgecomb, Taylor and Chapman, Alistair J and Pounders, Steffen and Burns, Kelly and Fisk, Chelsea S and Stowe, Alicia and Hill, Emily and Krech, Laura},
title = {Venous Thromboembolism Rates in Trauma Patients Significantly Increase With Missed Prophylactic Enoxaparin Doses},
journal = {The American Surgeon™},
year = {2024},
doi = {10.1177/00031348241269401}
}
EUVIMED